GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
24.56
+0.96 (4.07%)
Jan 6, 2026, 9:30 AM EST
GSK plc Market Cap
GSK plc has a market cap or net worth of $102.88 billion as of January 7, 2026. Its market cap has increased by 51.01% in one year.
Market Cap
102.88B
Enterprise Value
121.84B
Revenue
43.24B
Ranking
n/a
PE Ratio
13.93
Stock Price
$24.56
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 96.45B to 102.88B, an increase of 6.66%. That is a compound annual growth rate of 0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 102.79B | 4.33% |
| Dec 31, 2025 | 98.52B | 43.23% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |